Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C O Tacket

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|May 12, 1988
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coliC O Tacket, G Losonsky, H Link, et al.
American Journal of Epidemiology|May 1, 1985
An outbreak of Yersinia enterocolitica infections caused by contaminated tofu (soybean curd)C O Tacket, J Ballard, N Harris, et al.
Vaccine|August 1, 1994
Kinetics of the vibriocidal antibody response to live oral cholera vaccinesS S Wasserman, G A Losonsky, F Noriega, et al.
The American Journal of Tropical Medicine and Hygiene|April 17, 2001
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218R Edelman, C O Tacket, S S Wasserman, et al.
Nature Medicine|May 19, 1998
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potatoC O Tacket, H S Mason, G Losonsky, et al.
The Journal of Infectious Diseases|July 7, 2000
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoesC O Tacket, H S Mason, G Losonsky, et al.
Infection and Immunity|January 10, 1998
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallengeM S Donnenberg, C O Tacket, G Losonsky, et al.
Developments in Biological Standardization|January 1, 1994
Recombinant Salmonella vectors in vaccine developmentR Curtiss, S M Kelly, S A Tinge, et al.
The Journal of Infectious Diseases|April 1, 1991
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studiesC O Tacket, G Losonsky, D N Taylor, et al.
Vaccine|November 1, 1994
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheresC O Tacket, R H Reid, E C Boedeker, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|May 12, 1988
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coliC O Tacket, G Losonsky, H Link, et al.
American Journal of Epidemiology|May 1, 1985
An outbreak of Yersinia enterocolitica infections caused by contaminated tofu (soybean curd)C O Tacket, J Ballard, N Harris, et al.
Vaccine|August 1, 1994
Kinetics of the vibriocidal antibody response to live oral cholera vaccinesS S Wasserman, G A Losonsky, F Noriega, et al.
The American Journal of Tropical Medicine and Hygiene|April 17, 2001
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218R Edelman, C O Tacket, S S Wasserman, et al.
Nature Medicine|May 19, 1998
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potatoC O Tacket, H S Mason, G Losonsky, et al.
The Journal of Infectious Diseases|July 7, 2000
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoesC O Tacket, H S Mason, G Losonsky, et al.
Infection and Immunity|January 10, 1998
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallengeM S Donnenberg, C O Tacket, G Losonsky, et al.
Developments in Biological Standardization|January 1, 1994
Recombinant Salmonella vectors in vaccine developmentR Curtiss, S M Kelly, S A Tinge, et al.
The Journal of Infectious Diseases|April 1, 1991
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studiesC O Tacket, G Losonsky, D N Taylor, et al.
Vaccine|November 1, 1994
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheresC O Tacket, R H Reid, E C Boedeker, et al.
Pageof 9